MARAN, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 6492
EU - Europa 860
AS - Asia 513
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
SA - Sud America 3
Totale 7877
Nazione #
US - Stati Uniti d'America 6484
CN - Cina 372
FI - Finlandia 181
IT - Italia 174
UA - Ucraina 139
SE - Svezia 135
DE - Germania 129
VN - Vietnam 112
FR - Francia 42
GB - Regno Unito 34
TR - Turchia 15
IE - Irlanda 10
CA - Canada 8
EU - Europa 6
IN - India 6
RU - Federazione Russa 4
JP - Giappone 3
MA - Marocco 3
NL - Olanda 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
AT - Austria 1
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
IR - Iran 1
KR - Corea 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SY - Repubblica araba siriana 1
Totale 7877
Città #
Fairfield 927
Woodbridge 820
Houston 667
Jacksonville 641
Ann Arbor 567
Chandler 536
Wilmington 371
Ashburn 324
Seattle 306
Cambridge 298
Princeton 209
Roxbury 131
Dong Ket 112
San Diego 110
Medford 99
Padova 97
Beijing 87
Nanjing 87
Des Moines 66
Boardman 61
Helsinki 59
Nanchang 30
Shenyang 27
Hebei 25
Norwalk 23
Hefei 16
Jinan 14
Yenibosna 13
Dearborn 12
Jiaxing 12
Tianjin 12
Changsha 11
Lessolo 11
Dublin 10
Borås 6
Falls Church 6
Guangzhou 6
Fuzhou 5
Kharkiv 5
Kunming 5
Redwood City 5
Rome 5
Rostock 5
Rubano 5
Chengdu 4
Hangzhou 4
London 4
Ningbo 4
Norwich 4
Redmond 4
Toronto 4
Indiana 3
New York 3
Trieste 3
Windsor 3
Zhengzhou 3
Agordo 2
Baotou 2
Bloomington 2
Gouvieux 2
Marcianise 2
Nanning 2
Naples 2
Pavia 2
Rockville 2
San Francisco 2
San Jose 2
Sofia 2
Temara 2
Abano Terme 1
Ahmedabad 1
Amsterdam 1
Andover 1
Ardabil 1
Auburn Hills 1
Braunschweig 1
Brentford 1
Brighton 1
Buffalo 1
Cadoneghe 1
Castelnuovo Rangone 1
Catania 1
Cattolica 1
Charlottesville 1
Chongqing 1
Chuxiong 1
Costa Mesa 1
Galati 1
Gent 1
Guadalajara 1
Haikou 1
Hornchurch 1
Huzhou 1
Konya 1
Langfang 1
Lanzhou 1
Legnaro 1
Lisbon 1
Molise 1
Monmouth Junction 1
Totale 6944
Nome #
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 153
Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes 149
EFFECTS OF CHRONIC ALCOHOL INTAKE ON CARBOHYDRATE AND LIPID-METABOLISM IN SUBJECTS WITH TYPE-II (NON-INSULIN-DEPENDENT) DIABETES 138
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 128
Impaired cognitive processing speed in type 1 diabetic patients who had severe/recurrent hypoglycaemia 123
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 120
Glucose concentration can be predicted ahead in time from continuous glucose monitoring sensor time-series 113
Continuous glucose monitoring and hypo/hyperglycaemia prediction 111
A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 2) 105
Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and Type I diabetic subjects 104
EVIDENCE FOR REVERSIBILITY OF DEFECTIVE COUNTERREGULATION IN A PATIENT WITH INSULINOMA 103
Mechanisms of acute and chronic hypoglycemic action of gliclazide 102
Non-invasive glucose monitoring: Assessment of technologies and devices according to quantitative criteria 98
Glycaemic variability-based classification of impaired glucose tolerance vs. type 2 diabetes using continuous glucose monitoring data 98
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 91
Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations 90
Italian Contributions to the Development of Continuous Glucose Monitoring Sensors for Diabetes Management 89
Nocturnal hypoglycaemia in type 1 diabetes - consequences and assessment 84
Continuous subcutaneous glucose monitoring in diabetic patients - A multicenter analysis 83
Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 Diabetes 82
Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. 82
Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. 82
The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and Type 1 (insulin-dependent) diabetic humans 81
Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids 80
A telemedicine support for diabetes management: the T-IDDM project 80
From impaired glucose tolerance (IGT) to non-insulin dependent diabetes mellitus (NIDDM). Retrospective analysis of 632 observations 79
LACTATE DELAYS COUNTERREGULATION AND PROTECTS COGNITIVE FUNCTION DURING HYPOGLYCEMIA IN MAN 79
Alanine and late elevations of lactate are unable to act as significant non-glucose fuels during acute hypoglycemia 79
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 79
Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices 79
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries 78
Identification of individualised empirical models of carbohydrate and insulin effects on T1DM blood glucose dynamics 77
Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis 77
The Transcriptional Response in Human Umbilical Vein Endothelial Cells Exposed to Insulin: a Dynamic Gene Expression Approach. 76
Cognitive, neurophysiologic and metabolic sequelae of previous hypoglycemic coma revealed by hyperinsulinemic-hypoglycemic clamp in type 1 diabetic patients 76
Effect of baseline glycosylated hemoglobin A1c on glycemic control and diabetes management following initiation of once-daily insulin detemir in real-life clinical practice. 73
Lactate rescues cognitive function and counterregulatory responses during hypoglycemia. 72
Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide. 72
Practical guidance to insulin management. 72
Delayed Nocturnal Hypoglycemia In Type 1 Diabetic Patients: Effect Of Two Different Exercise Modalities 71
Continuous glucose monitoring time series and hypo/hyperglycemia prevention: requirements, methods, open problems. 71
PROTECTION BY LACTATE OF CEREBRAL FUNCTION DURING HYPOGLYCEMIA 71
Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter evaluation 70
Use of an integrated strip-free blood glucose monitoring system increases frequency of self-monitoring and improves glycemic control: Results from the ExAct study 70
Role of anti-granulocyte Fab ' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results 70
LACK OF PROTECTION OF CEREBRAL FUNCTION IN WELL CONTROLLED DIABETIC-PATIENTS WITH HYPOGLYCEMIA UNAWARENESS 69
Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects 69
Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment 68
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 68
The metabolic syndrome in the European population: The experience of the European group on insulin resistance (EGIR) 67
Sequelae of acute hypoglycaemia on 24 hour blood pressure and metabolic parameters in normal and type 1 (insulin-dependent) diabetic individuals. 67
DOUBLE-BLIND CLINICAL AND LABORATORY STUDY OF HYPOGLYCEMIA WITH HUMAN AND PORCINE INSULIN IN DIABETIC-PATIENTS REPORTING HYPOGLYCEMIA UNAWARENESS AFTER TRANSFERRING TO HUMAN INSULIN 66
Personalized Subcutaneous Model-Predictive Closed-Loop Control of T1DM: Pilot Studies in the USA and Italy 65
The GesTIO protocol experience: safety of a standardized order set for subcutaneous insulin regimen in elderly hospitalized patients 65
LACK OF PRESERVATION OF HIGHER BRAIN-FUNCTION DURING HYPOGLYCEMIA IN PATIENTS WITH INTENSIVELY-TREATED IDDM 64
Glucose Rate of Appearance and Subcutaneous Insulin Absorption Models for Use in Prediction Algorithms. 63
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine 63
Metabolic control determines the endothelial function in IDDM patients. 62
Counterregulatory response to insulin-induced hypoglycemia differs between male and female insulin-dependent diabetic patients 61
Alanine and late elevations of lactate are unable to act as significant non-glucose fuels during acute hypoglycemia. 61
High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. 61
Comparison between CSII with multiple basal lispro infusion rates and MDI with lispro and glargine 60
Hypoglycemic syndrome in a patient with proinsulin-only secreting pancreatic adenoma (proinsulinoma). 60
Continuous subcutaneous glucose monitoring: the Glucoday system 59
Design, methods, and evaluation directions of a multi-access service for the management of diabetes mellitus patients 59
Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice 57
Early insulin secretion is a determinant of glucose tolerance in diabetic and non-diabetic subjects 57
Ambulatory Glucose Profile Applied to Flash Glucose Monitoring in Real Life: An Expert Opinion 56
Identification of asymptomatic hypoglycaemia in patients with insulinoma with continuous glucose monitoring 55
Caso di ipoglicemia autoimmune trattata con plasmaferesi 53
HYPOGLYCEMIA IN INSULIN-DEPENDENT DIABETES-MELLITUS - FACTS FOR THE 1990S 53
Continuous glucose monitoring in conditions other than diabetes 53
Nitric oxide contribution to hemodynamic alterations of diabetic ketosis 52
Accuracy of continuous subcutaneous glucose monitoring in detecting hypoglycemia in diabetic patients 51
Multi-access services for the management of diabetes mellitus: The M2DM project 50
One-year caloric restriction and 12-week exercise training intervention in obese adults with type 2 diabetes: emphasis on metabolic control and resting metabolic rate 49
A randomized crossover study to compare continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) in type 1 diabetic patients previously treated with CSII 48
Observational study of once-daily insulin detemir in people with type 2 diabetes aged 75 years or older: a sub-analysis of data from the Study of Once daily LeVEmir (SOLVE). 48
Effect of an alpha-glycosidase inhibitor acarbose (BAY G 5421) on diurnal glucose metabolic variations 48
Research methodologies in hypoglycaemia: counterregulation phenomena and nerve/brain dysfunction 47
Real-Time Continuous Glucose Monitoring in Adult OutpatientsTechnological Advances in the Treatment of Type 1 Diabetes 46
Support vector machine fed by CGM-based glycemic variability indices can distinguish between IGT and T2D subjects 46
A post-hypoglycaemic increase of lactate can rescue cognitive function and counterregulatory responses to hypoglycaemia 46
The role of nitric oxide in the hemodynamic disturbances of decompensated insulin-dependent diabetes 45
PREVIOUS HYSTORY OF HYPOGLYCEMIC COMA DETERMINES COGNITIVE AND EEG ABNORMALITIES DURING HYPOGLYCEMIA IN TYPE 1 DIABETIC PATIENTS 45
The Multi-Modular Model Predictive Control-to-Range (MPC2R) Allows Simultaneous Improvement in Safety and Efficacy of Closed-Loop Insulin Delivery in Type 1 Diabetes (T1D) 45
Glucose prediction from continuous subcutaneous monitoring data 44
Dolore e diabete 44
Insulinoma diagnosis: role of continuous subcutaneous glucose monitoring 43
Multi-access services for the management of diabetes mellitus: The M2DM project 43
IGT and T2D subjects automatically classified using a selection of CGM-based glycemic variability indices 43
The plurimetabolic syndrome in the european population: the experience of the European Group of insulin resistance (EGIR) 42
L'ipoglicemia 42
Early insulin secretion is a determinant of glucose tolerance in diabetic and non-diabetic subjects 42
ExAct study: Integrated strip-free SMBG technology (Accu-Chek (R) Mobile) improves patient adherence to recommended testing frequency and patterns and glycaemic control 42
Diagnostica clinica dell'ipoglicemia nel diabete mellito 41
UNRELIABILITY OF REPORTS OF HYPOGLYCEMIA BY DIABETIC-PATIENTS 41
GENDER DIFFERENCES IN COUNTERREGULATION TO HYPOGLYCEMIA 41
Improvement in cognitive dysfunction by high blood lactate levels during hypoglycaemia in type 1 diabetic patients. 40
LeukoScan in bone infection evaluation: Technical procedure and scan interpretative criteria 40
Totale 6975
Categoria #
all - tutte 14067
article - articoli 11331
book - libri 64
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 474
Totale 25936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018103 0000 00 00 408613
2018/2019747 831702 98 368 497196179
2019/20201467 2523723112 117134 185164 12514964105
2020/20211466 3611925154 42126 26111 240221182184
2021/20221552 45223187123 4582 58196 6120147365
2022/20231093 2989423117 202147 597 110000
Totale 7921